Thursday, 05 May 2022
Members of the public are invited learn how this important area of research will be addressed and to officially see the launch of the Advance Pain Discover Platform (APDP), at a webinar on the 9 May from 10am – 12midday.
The problem of pain still blights the lives of far too many people. Around a third of the population in Britain have chronic pain. This long-lasting pain affects so many aspects of people’s lives, their ability to work and personal relationships.
The UK has been the cornerstone of pain research. The APDP is a new, unique partnership that has developed from a shared vision, funded by government, charities and the private sector. It is a multi-million pound, long-term initiative that will generate research science to break through the complexity of pain.
The APDP brings people with lived experience of pain together with UK excellence in chronic pain research across diagnoses, disciplines, academic, clinical and commercial communities.
Together, through the APDP, we will transform people鈥檚 understanding of pain. We will uncover shared mechanisms and break down inconsistencies in diagnosis and treatment.
"We will uncover genes and molecules, brain structure and function, psychological and social mechanisms, drug and non-drug treatments. Those who are forced to live with intolerable pain are being noticed. Our multidisciplinary approach will ultimately improve the lives of people living with pain conditions and their families.鈥�
鈥淲e will uncover genes and molecules, brain structure and function, psychological and social mechanisms, drug and non-drug treatments. Those who are forced to live with intolerable pain are being noticed. Our multidisciplinary approach will ultimately improve the lives of people living with pain conditions and their families.鈥�
The webinar will convey for a public audience the specific and shared ambitions of each of the 18 current APDP components. Attendees will see the depth and breadth of UK capability in pain research, and have an opportunity to initiate new links with our experts.
To register to attend the webinar visit -
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.